EPA:MEDCL - Euronext Paris - Matif - FR0004065605 - Common Stock - Currency: EUR
TTM (2024-9-30) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
---|---|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
Net Income | -31.45M | N/A | -25.04M | -32.01M | -24.81M | |||
Depreciation Amortization | 1.70M | N/A | 1.72M | 1.67M | 1.52M | |||
Change In Working Capital | 36.08M | N/A | 3.09M | -3.04M | -2.37M | |||
Interest Paid | 1.03M | N/A | 2.15M | 4.46M | 1.13M | |||
Other non cash items | 15.07M | N/A | 8.31M | 12.38M | 4.29M | |||
OPERATING CASH FLOW | 21.39M | 19.00M | -11.92M | -21.00M | -21.36M | |||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
Capital Expenditure | -1.29M | N/A | -1.19M | -1.03M | -1.97M | |||
Other Investing Activity | -6.13M | N/A | 578.00K | 2.33M | 1.66M | |||
INVESTING CASH FLOW | -7.42M | -13.00M | -613.00K | 1.30M | -316.00K | |||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
Debt Issued/Reduced | -8.42M | N/A | 4.38M | 5.21M | 470.00K | |||
Stock Issued/Repurchased | 316.00K | N/A | 23.30M | 810.00K | -144.00K | |||
Other Financing Activity | -1.03M | N/A | -2.15M | -4.46M | -1.13M | |||
FINANCING CASH FLOW | -9.13M | 33.00M | 25.53M | 1.56M | -800.00K | |||
Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
CHANGE IN CASH | 4.86M | 39.00M | 12.99M | -18.15M | -22.48M | |||
FREE CASH FLOW | ||||||||
Operating Cash Flow | 21.39M | 19.00M | -11.92M | -21.00M | -21.36M | |||
Capital Expenditure | -1.29M | N/A | -1.19M | -1.03M | -1.97M | |||
FREE CASH FLOW | 20.11M | 19.00M | -13.11M | -22.03M | -23.34M |
All data in EUR